Amy Walker Buys 2,650 Shares of 4basebio (LON:4BB) Stock

4basebio PLC (LON:4BB) insider Amy Walker acquired 2,650 shares of the company’s stock in a transaction on Friday, February 13th. The stock was acquired at an average cost of GBX 586 per share, with a total value of £15,529.

4basebio Trading Up 2.7%

Shares of LON 4BB opened at GBX 580 on Wednesday. The business’s 50 day moving average is GBX 595.23 and its two-hundred day moving average is GBX 725.03. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. 4basebio PLC has a 1-year low of GBX 520 and a 1-year high of GBX 1,220. The stock has a market capitalization of £89.81 million, a P/E ratio of -5.86 and a beta of 1.09.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.